DE69329550T2 - 2,5-diaryl tetrahydro-thiopene, -furane und analoge zur behandlung von entzündungs-und immunkrankheiten - Google Patents
2,5-diaryl tetrahydro-thiopene, -furane und analoge zur behandlung von entzündungs-und immunkrankheitenInfo
- Publication number
- DE69329550T2 DE69329550T2 DE69329550T DE69329550T DE69329550T2 DE 69329550 T2 DE69329550 T2 DE 69329550T2 DE 69329550 T DE69329550 T DE 69329550T DE 69329550 T DE69329550 T DE 69329550T DE 69329550 T2 DE69329550 T2 DE 69329550T2
- Authority
- DE
- Germany
- Prior art keywords
- diaryl
- inflammatory
- thiopene
- furane
- tetrahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/912,788 US5358938A (en) | 1992-07-13 | 1992-07-13 | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US07/933,991 US5434151A (en) | 1992-08-24 | 1992-08-24 | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US08/062,391 US5648486A (en) | 1992-07-13 | 1993-05-12 | Compounds and methods for the treatment of inflammatory and immune disorders |
PCT/US1993/006575 WO1994001430A1 (en) | 1992-07-13 | 1993-07-13 | 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69329550D1 DE69329550D1 (de) | 2000-11-16 |
DE69329550T2 true DE69329550T2 (de) | 2001-05-31 |
Family
ID=27129612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69329550T Expired - Fee Related DE69329550T2 (de) | 1992-07-13 | 1993-07-13 | 2,5-diaryl tetrahydro-thiopene, -furane und analoge zur behandlung von entzündungs-und immunkrankheiten |
Country Status (13)
Country | Link |
---|---|
US (2) | US6294574B1 (de) |
EP (1) | EP0650485B1 (de) |
JP (1) | JPH08502243A (de) |
AT (1) | ATE196903T1 (de) |
AU (1) | AU666578B2 (de) |
CA (1) | CA2140034A1 (de) |
DE (1) | DE69329550T2 (de) |
DK (1) | DK0650485T3 (de) |
ES (1) | ES2152952T3 (de) |
GR (1) | GR3035063T3 (de) |
HU (1) | HUT72601A (de) |
PT (1) | PT650485E (de) |
WO (1) | WO1994001430A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5639782A (en) * | 1992-03-04 | 1997-06-17 | Center For Innovative Technology | Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
US5434151A (en) * | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5463083A (en) * | 1992-07-13 | 1995-10-31 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
ES2152952T3 (es) | 1992-07-13 | 2001-02-16 | Millennium Pharm Inc | 2,5-diaril tetrahidro-tiofenos, -furanos y analogos para el tratamiento de problemas inflamatorios e inmunes. |
US5750565A (en) | 1995-05-25 | 1998-05-12 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
DE69532077T2 (de) * | 1994-06-27 | 2004-09-02 | Millennium Pharmaceuticals, Inc., Cambridge | Verbindungen und verfahren zur behandlung von cardiovaskulären, inflammatorischen und das immunsystem betreffende erkrankungen |
US5703093A (en) * | 1995-05-31 | 1997-12-30 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5792776A (en) * | 1994-06-27 | 1998-08-11 | Cytomed, Inc., | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
WO2000001683A1 (en) | 1998-07-03 | 2000-01-13 | Leukosite, Inc. | Methods for synthesis of substituted tetrahydrofuran compound |
CA2345919A1 (en) | 1998-07-03 | 2000-01-13 | Gangavaram Vasantha Madhava Sharma | Substituted oxygen alicyclic compounds, including methods for synthesis thereof |
CA2356841A1 (en) * | 1998-07-03 | 2000-01-13 | Millennium Pharmaceuticals, Inc. | Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof |
US6255498B1 (en) | 1998-10-16 | 2001-07-03 | Millennium Pharmaceuticals, Inc. | Method for synthesizing diaryl-substituted heterocyclic compounds, including tetrahydrofurans |
BRPI1014405A2 (pt) | 2009-04-29 | 2016-04-05 | Amarin Corp Plc | composições farmacêuticas compreendendo epa e um agente cardiovascular e métodos de seu uso |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2690988A (en) | 1952-12-24 | 1954-10-05 | Stauffer Chemical Co | Insecticidal substituted 1, 3-dithiolanes and method of application |
US3852601A (en) | 1971-07-15 | 1974-12-03 | Ital Elettionica Spa | Scanning device for scintigraphy according to three orthogonal planes |
US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US4539332A (en) * | 1983-11-14 | 1985-09-03 | Merck & Co., Inc. | 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists |
US4656190A (en) | 1983-11-14 | 1987-04-07 | Merck & Co., Inc. | Indene derivatives and their use as PAF-antagonists |
US4757084A (en) * | 1984-02-29 | 1988-07-12 | Merck & Co., Inc. | 2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antagonists |
US4595693A (en) | 1984-06-04 | 1986-06-17 | Merck & Co., Inc. | Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists |
US4871756A (en) | 1985-03-20 | 1989-10-03 | Merck Frosst Canada, Inc. | Leukotriene antagonists |
US4604407A (en) | 1985-04-04 | 1986-08-05 | E. R. Squibb & Sons, Inc. | Hydroxamates |
NZ215866A (en) * | 1985-04-22 | 1989-11-28 | Merck & Co Inc | 2,5-di(aryl/heterocyclyl) tetrahydro-furans and pharmaceutical compositions |
US4876346A (en) | 1985-05-02 | 1989-10-24 | American Home Products Corporation | Quinoline compounds |
US4891363A (en) | 1985-07-26 | 1990-01-02 | Sankyo Company Limited | Cyclic ether derivatives and their use |
DE3701344A1 (de) | 1986-01-21 | 1987-07-23 | Boehringer Ingelheim Kg | Neue thieno-1,4-diazepine |
FR2601016B1 (fr) | 1986-07-04 | 1988-10-07 | Rhone Poulenc Sante | Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent |
US4910206A (en) | 1986-07-14 | 1990-03-20 | Sandoz Pharmaceuticals Corp. | 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists |
DE3724031A1 (de) | 1986-07-22 | 1988-01-28 | Boehringer Ingelheim Kg | Neue hetrazepine und verfahren zu ihrer herstellung |
DE3724164A1 (de) | 1986-07-25 | 1988-01-28 | Boehringer Ingelheim Kg | Neue 1,4-benzodiazepine, ihre herstellung und verwendung |
DE3778248D1 (de) | 1986-08-21 | 1992-05-21 | Merck & Co Inc | 1,3-diarylcyclopentane und deren abkoemmlinge als paf-antagonisten. |
US4841968A (en) | 1986-09-26 | 1989-06-27 | Southern Research Institute | Antithrombotic/thrombolytic suture and methods of making and using the same |
GB2197650A (en) * | 1986-11-21 | 1988-05-25 | Merck & Co Inc | Process for preparing 2,5-diphenyl tetrahydrofurans and analogs thereof |
US4873259A (en) | 1987-06-10 | 1989-10-10 | Abbott Laboratories | Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
CN1030415A (zh) | 1987-02-20 | 1989-01-18 | 山之内制药株式会社 | 饱和的杂环碳酰胺衍生物和它的制备方法 |
US4916145A (en) | 1987-07-10 | 1990-04-10 | Hoffmann-La Roche Inc. | Substituted n-[(pyridyl)alkyl]aryl-carboxamide |
GB2209031A (en) | 1987-08-24 | 1989-04-26 | Merck & Co Inc | Processes for preparing 1,3-diaryl cyclopentanes and derivatives thereof as PAF antagonists |
CA1334975C (en) | 1987-11-13 | 1995-03-28 | James H. Holms | Furan and pyrrole containing lipoxygenase inhibiting compounds |
JPH01149764A (ja) | 1987-12-07 | 1989-06-12 | Green Cross Corp:The | ビス−s−アルキルベンゼン誘導体 |
US4959361A (en) | 1987-12-18 | 1990-09-25 | Hoffmann-La Roche Inc. | Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists |
NZ227287A (en) * | 1987-12-21 | 1992-01-29 | Merck & Co Inc | 2,5-diaryl tetrahydrofurans and medicaments |
US4996203A (en) * | 1987-12-21 | 1991-02-26 | Merck & Co., Inc. | 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists |
US4845129A (en) | 1988-03-14 | 1989-07-04 | Sandoz Pharm. Corp. | Diaryl substituted cyclopentane and cyclopentene derivatives |
EP0338993A1 (de) | 1988-04-21 | 1989-10-25 | Sandoz Ag | 6-Aryl-substituierte 4H-Thieno [2,3-e][1,2,4] triazole [3,4-c] [1,4] diazepine |
US4992428A (en) | 1988-05-05 | 1991-02-12 | Sandoz Pharm. Corp. | 5-aryl-substituted-2,3-dihydro-imidazo[1,2-a]furo- and thieno pyridines |
EP0365089A3 (de) * | 1988-10-18 | 1991-06-05 | Merck & Co. Inc. | 2-Aryl-5(3-methoxy-5-(hydroxypropylsulfonyl)-4-propoxyphenyl)tetrahydrothiophen und Analoge |
FI95708C (fi) | 1988-10-31 | 1996-03-11 | Eisai Co Ltd | Analogiamenetelmä 1,4-diatsepiinijohdannaisen ja sen farmaseuttisesti sopivan suolan valmistamiseksi |
DE3936828A1 (de) | 1988-11-06 | 1990-05-10 | Boehringer Ingelheim Kg | Neue hetrazepine |
US5234950A (en) | 1988-12-23 | 1993-08-10 | Imperial Chemical Industries Plc | Tetrahydrofuran derivatives |
US5175183A (en) | 1989-02-01 | 1992-12-29 | Abbott Laboratories | Lipoxygenase inhibiting compounds |
DE4006471A1 (de) | 1989-03-03 | 1990-09-06 | Boehringer Ingelheim Kg | Neue thienodiazepine |
FR2644456B1 (fr) | 1989-03-17 | 1991-07-05 | Rhone Poulenc Sante | Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent |
GB8907401D0 (en) | 1989-04-01 | 1989-05-17 | Pfizer Ltd | Therapeutic agents |
US5001123A (en) * | 1989-06-08 | 1991-03-19 | Merck & Co., Inc. | 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists |
US4977146A (en) * | 1989-06-08 | 1990-12-11 | Merck & Co., Inc. | 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists |
US5011847A (en) * | 1989-06-08 | 1991-04-30 | Merck & Co., Inc. | 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists |
PH30133A (en) | 1989-09-07 | 1997-01-21 | Abbott Lab | Indole-, benzofuran-, and benzothiophene-containing lipoxygenase inhibiting compounds |
US5037853A (en) | 1989-12-28 | 1991-08-06 | Abbott Laboratories | Cyclopropyl derivative lipoxygenase inhibitors |
GB9009469D0 (en) | 1990-04-27 | 1990-06-20 | British Bio Technology | Compounds |
US5244896A (en) | 1990-09-14 | 1993-09-14 | Marion Merrell Dow Inc. | Carbocyclic adenosine analogs useful as immunosuppressants |
JP3007138B2 (ja) * | 1990-11-27 | 2000-02-07 | ファイザー製薬株式会社 | 新規なヒドロキサム酸とn―ヒドロキシ尿素誘導体およびそれらの組成物 |
US5110831A (en) | 1990-11-30 | 1992-05-05 | Du Pont Merck Pharmaceutical Company | Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors |
JPH0730061B2 (ja) | 1991-02-07 | 1995-04-05 | ファイザー製薬株式会社 | ヒドロキサム酸誘導体および組成物 |
DK0574510T3 (da) | 1991-03-04 | 2001-12-03 | Univ Virginia | 2,4-Diaryl-1,3-dithiolaner som platelet activating faktor receptorblokkere og 5-lipoxygenasehæmmere |
US5420164A (en) | 1991-04-04 | 1995-05-30 | Yoshitomi Pharmaceutical Industries, Ltd. | Cycloalkylurea compounds |
RU2059603C1 (ru) | 1991-05-09 | 1996-05-10 | Хоффманн-Ля Рош АГ | ПРОИЗВОДНЫЕ α -ЗАМЕЩЕННЫХ АРИЛУКСУСНЫХ КИСЛОТ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ |
US5147893A (en) | 1991-05-09 | 1992-09-15 | G. D. Searle & Co. | Cyclic phenolic thioethers |
GB9114337D0 (en) | 1991-07-03 | 1991-08-21 | British Bio Technology | Compounds |
US5183818A (en) | 1991-08-27 | 1993-02-02 | Abbott Laboratories | Arylalkylether and arylalkylthioether inhibitors of lipoxygenase enzyme activity |
GB9200210D0 (en) | 1992-01-07 | 1992-02-26 | British Bio Technology | Compounds |
GB9202791D0 (en) | 1992-02-11 | 1992-03-25 | British Bio Technology | Compounds |
US5169854A (en) | 1992-02-26 | 1992-12-08 | Abbott Laboratories | N-substituted-furylalkenyl hydroxamic acid and N-hydroxyurea compounds having lipoxygenase inhibitory activity |
US5639782A (en) | 1992-03-04 | 1997-06-17 | Center For Innovative Technology | Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
US5187192A (en) | 1992-03-13 | 1993-02-16 | Abbott Laboratories | Cyclobutyl derivatives having lipoxygenase inhibitory activity |
US5326787A (en) | 1992-05-12 | 1994-07-05 | Abbott Laboratories | Cycloalkyl N-hydroxy derivatives having lipoxygenase inhibitory activity |
ES2152952T3 (es) | 1992-07-13 | 2001-02-16 | Millennium Pharm Inc | 2,5-diaril tetrahidro-tiofenos, -furanos y analogos para el tratamiento de problemas inflamatorios e inmunes. |
US5358938A (en) | 1992-07-13 | 1994-10-25 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5434151A (en) | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5463083A (en) | 1992-07-13 | 1995-10-31 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
EP0656004A1 (de) | 1992-08-20 | 1995-06-07 | Cytomed, Inc. | Entzündungshemmende und immunsuppressive mittel mit zweifacher wirkungsweise |
US5288751A (en) | 1992-11-06 | 1994-02-22 | Abbott Laboratories | [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis |
ES2062943B1 (es) | 1993-03-23 | 1995-11-16 | Uriach & Cia Sa J | Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas. |
DE69532077T2 (de) | 1994-06-27 | 2004-09-02 | Millennium Pharmaceuticals, Inc., Cambridge | Verbindungen und verfahren zur behandlung von cardiovaskulären, inflammatorischen und das immunsystem betreffende erkrankungen |
-
1993
- 1993-07-13 ES ES93918182T patent/ES2152952T3/es not_active Expired - Lifetime
- 1993-07-13 JP JP6503572A patent/JPH08502243A/ja not_active Ceased
- 1993-07-13 AT AT93918182T patent/ATE196903T1/de not_active IP Right Cessation
- 1993-07-13 EP EP93918182A patent/EP0650485B1/de not_active Expired - Lifetime
- 1993-07-13 CA CA002140034A patent/CA2140034A1/en not_active Abandoned
- 1993-07-13 AU AU47722/93A patent/AU666578B2/en not_active Ceased
- 1993-07-13 HU HU9500099A patent/HUT72601A/hu unknown
- 1993-07-13 PT PT93918182T patent/PT650485E/pt unknown
- 1993-07-13 DE DE69329550T patent/DE69329550T2/de not_active Expired - Fee Related
- 1993-07-13 WO PCT/US1993/006575 patent/WO1994001430A1/en active IP Right Grant
- 1993-07-13 DK DK93918182T patent/DK0650485T3/da active
-
1995
- 1995-06-06 US US08/469,073 patent/US6294574B1/en not_active Expired - Fee Related
-
2000
- 2000-04-11 US US09/547,941 patent/US20020177723A1/en not_active Abandoned
- 2000-12-13 GR GR20000402751T patent/GR3035063T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0650485B1 (de) | 2000-10-11 |
ES2152952T3 (es) | 2001-02-16 |
US6294574B1 (en) | 2001-09-25 |
AU4772293A (en) | 1994-01-31 |
HUT72601A (en) | 1996-05-28 |
HU9500099D0 (en) | 1995-03-28 |
WO1994001430A1 (en) | 1994-01-20 |
DK0650485T3 (da) | 2001-01-22 |
AU666578B2 (en) | 1996-02-15 |
CA2140034A1 (en) | 1994-01-20 |
ATE196903T1 (de) | 2000-10-15 |
US20020177723A1 (en) | 2002-11-28 |
PT650485E (pt) | 2001-03-30 |
GR3035063T3 (en) | 2001-03-30 |
DE69329550D1 (de) | 2000-11-16 |
JPH08502243A (ja) | 1996-03-12 |
EP0650485A1 (de) | 1995-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69532077D1 (de) | Verbindungen und verfahren zur behandlung von cardiovaskulären, inflammatorischen und das immunsystem betreffende erkrankungen | |
DE69329550T2 (de) | 2,5-diaryl tetrahydro-thiopene, -furane und analoge zur behandlung von entzündungs-und immunkrankheiten | |
ATE202140T1 (de) | Hemmung der neovaskulasierung durch vegf- spezifische oligonukleotide | |
CA2168963A1 (en) | Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases | |
UA39166C2 (uk) | Похідні n-гідроксисечовини, що є інгібіторами ліпоксигенази у ссавців, спосіб їх одержання і спосіб інгібування ліпоксигенази у ссавців | |
ATE184792T1 (de) | 2-bromomelatonin zur behandlung von schlafstörungen | |
FI925342A (fi) | Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi | |
DE69402173D1 (de) | Hemmung von Thrombin | |
BG103575A (en) | SUBSTITUTED NITROGENCONTAINING HETEROCYCLES AS p38 PROTEINKINASE INHIBIRORS | |
DE60225556D1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
MXPA04005790A (es) | Compuestos y usos de los mismos para reducir la actividad de la lipasa sensible a la hormona. | |
ATE321548T1 (de) | Verwendung von statin zur behandlung von hauterkrankungen | |
ES2087038A1 (es) | Nuevas piperidinas con actividad antagonista del paf. | |
MA26732A1 (fr) | Composition pharmaceutique nouvelle comprenant un inhibiteur de nos, et procede pour sa preparation | |
ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
DE60306503D1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
FR2658190B1 (fr) | Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant. | |
DE3875065D1 (de) | Verwendung von nalmefen zur herstellung eines arzneimittels zur behandlung der schaedigung des zentralnervensystems. | |
WO1997019669A3 (en) | Heterocyclic compounds and their use | |
GEP19971029B (en) | Antiviral or antibacterial compound and method of use thereof | |
MX9704740A (es) | Monomeros de 3,3-(disustituido)ciclohexan-1-ol y compuestos relacionados. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |